{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:26:27Z","timestamp":1793946387698,"version":"4.8.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010413","name":"Rene Baron Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031162","name":"Sanford Burnham Prebys","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020087","name":"Williams Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017651","name":"Richard Lounsbery Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017651","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fund for Scientific and Technological Research","doi-asserted-by":"publisher","award":["PICT 2020-01552"],"award-info":[{"award-number":["PICT 2020-01552"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Argentina Ministry of Science Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbagen.2026.130931","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:24:35Z","timestamp":1773332675000},"page":"130931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the role of sialidases in Galectin-1-associated resistance to cancer therapies"],"prefix":"10.1016","volume":"1870","author":[{"given":"Marco A.","family":"Scheidegger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn P.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago N.","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirta","family":"Schattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego O.","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Dalotto-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina V.","family":"Mari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel A.","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.130931_bb0005","series-title":"Essentials of Glycobiology","article-title":"Cellular Organization of Glycosylation","author":"Colley","year":"2022"},{"key":"10.1016\/j.bbagen.2026.130931_bb0010","series-title":"Essentials of Glycobiology","article-title":"Glycosylation Changes in Cancer","author":"Bellis","year":"2022"},{"key":"10.1016\/j.bbagen.2026.130931_bb0015","article-title":"Altered glycosylation in cancer: a promising target for biomarkers and therapeutics","volume":"1875","author":"Thomas","year":"2021","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"key":"10.1016\/j.bbagen.2026.130931_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20182041","article-title":"Sweetening the hallmarks of cancer: galectins as multifunctional mediators of tumor progression","volume":"217","author":"Girotti","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2026.130931_bb0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","article-title":"Glycosylation in the era of Cancer-targeted therapy: where are we heading?","volume":"36","author":"Mereiter","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagen.2026.130931_bb0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.trecan.2020.04.002","article-title":"Targeting glycosylation: a new road for cancer drug discovery","volume":"6","author":"Costa","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbagen.2026.130931_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00028","article-title":"Altered tumor-cell glycosylation promotes metastasis","volume":"4","author":"H\u00e4uselmann","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/bs.acr.2014.11.001","article-title":"Glycans and cancer: role of N-Glycans in cancer biomarker, progression and metastasis, and therapeutics","volume":"126","author":"Taniguchi","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130931_bb0050","series-title":"Adv. Clin. Chem.","first-page":"249","article-title":"Tumor-associated carbohydrate antigens: Biomarker discovery and clinical application","author":"Freire","year":"2025"},{"key":"10.1016\/j.bbagen.2026.130931_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/73163","article-title":"Suppression of tumor growth and metastasis in Mgat5-deficient mice","volume":"6","author":"Granovsky","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2026.130931_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104507","article-title":"Advances in antibody-based strategies for targeting cancer-associated glycopeptide antigens","volume":"30","author":"Meier","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbagen.2026.130931_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102395","article-title":"Reading the glyco-code: new approaches to studying protein\u2013carbohydrate interactions","volume":"75","author":"Wisnovsky","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2025.04.027","article-title":"Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells","author":"Blidner","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.bbagen.2026.130931_bb0075","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","article-title":"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors","volume":"156","author":"Croci","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2026.130931_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2024.101913","article-title":"The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs","volume":"76","author":"Nardini","year":"2024","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0085","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","article-title":"Global view of human protein glycosylation pathways and functions","volume":"21","author":"Schjoldager","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0090","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/0008-5472.CAN-12-2418","article-title":"Targeting Galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease","volume":"73","author":"Dalotto-Moreno","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130931_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-023-00636-2","article-title":"Targeting galectin-driven regulatory circuits in cancer and fibrosis","volume":"22","author":"Mari\u00f1o","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2026.130931_bb0100","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1084\/jem.20111665","article-title":"Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi\u2019s sarcoma","volume":"209","author":"Croci","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2026.130931_bb0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3390\/ijms23010316","article-title":"Galectins as emerging Glyco-checkpoints and therapeutic targets in glioblastoma","volume":"23","author":"Videla-Richardson","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jitc-2024-008984","article-title":"Do galectins serve as soluble ligands for immune checkpoint receptors?","volume":"12","author":"Torres","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbagen.2026.130931_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00109","article-title":"Turning-off signaling by siglecs, selectins, and galectins: chemical inhibition of glycan-dependent interactions in cancer","volume":"6","author":"Cagnoni","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2026.130931_bb0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0130","article-title":"Sialic acid and Siglec receptors in tumor immunity and immunotherapy","volume":"74\u201375","author":"Mantuano","year":"2024","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0135","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nri.2018.3","article-title":"The tumour glyco-code as a novel immune checkpoint for immunotherapy","volume":"18","author":"Rodr\u00cdguez","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105400","article-title":"The universe of galectin-binding partners and their functions in health and disease","volume":"299","author":"Troncoso","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0145","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1242\/jcs.151159","article-title":"The galectin lattice at a glance","volume":"128","author":"Nabi","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0150","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.208884","article-title":"Galectins at a glance","volume":"131","author":"Johannes","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0155","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cytogfr.2013.07.003","article-title":"Vascular galectins: regulators of tumor progression and targets for cancer therapy","volume":"24","author":"Thijssen","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbagen.2026.130931_bb0160","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2012-12-474569","article-title":"Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma","volume":"121","author":"Ouyang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2026.130931_bb0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424051122","article-title":"Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells","volume":"122","author":"Vinaixa","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0170","article-title":"Galectin-1-induced autophagy facilitates cisplatin resistance of hepatocellular carcinoma","volume":"11","author":"Su","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2026.130931_bb0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.taap.2008.01.009","article-title":"Evidence of galectin-1 involvement in glioma chemoresistance","volume":"229","author":"Le Mercier","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0180","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/sj.jid.5700869","article-title":"Galectin-1 knockdown increases sensitivity to Temozolomide in a B16F10 mouse metastatic melanoma model","volume":"127","author":"Mathieu","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1722434115","article-title":"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor\u2013stroma crosstalk","volume":"115","author":"Orozco","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0190","doi-asserted-by":"crossref","first-page":"83611","DOI":"10.18632\/oncotarget.13201","article-title":"Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway","volume":"7","author":"Chong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagen.2026.130931_bb0195","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/cas.12539","article-title":"Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin \u03b21","volume":"105","author":"He","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2214350120","article-title":"Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology","volume":"120","author":"Bannoud","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0205","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/j.jmb.2016.03.021","article-title":"Shaping the immune landscape in cancer by galectin-driven regulatory pathways","volume":"428","author":"Rabinovich","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0210","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.4049\/jimmunol.0803811","article-title":"Galectin-1 Tunes TCR binding and signal transduction to regulate CD8 burst size","volume":"182","author":"Liu","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1535-6108(04)00024-8","article-title":"Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: a potential mechanism of tumor-immune privilege","volume":"5","author":"Rubinstein","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagen.2026.130931_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2102950118","article-title":"Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells","volume":"118","author":"Cagnoni","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbagen.2026.130931_bb0225","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1158\/1078-0432.CCR-18-3870","article-title":"Impact of galectins in resistance to anticancer therapies","volume":"26","author":"Navarro","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130931_bb0230","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"Toscano","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2011\/374314","article-title":"Mgat5 deficiency in T cells and experimental autoimmune encephalomyelitis","volume":"2011","author":"Grigorian","year":"2011","journal-title":"ISRN Neurol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0240","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/MCB.26.8.3181-3193.2006","article-title":"Galectin binding to Mgat5-modified N-Glycans regulates fibronectin matrix remodeling in tumor cells","volume":"26","author":"Lagana","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0245","series-title":"Essentials of Glycobiology","article-title":"Sialic acids and other nonulosonic acids","author":"Lewis","year":"2022"},{"key":"10.1016\/j.bbagen.2026.130931_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00138","article-title":"Biosynthetic machinery involved in aberrant glycosylation: promising targets for developing of drugs against cancer","volume":"5","author":"Vasconcelos-dos-Santos","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0255","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1073\/pnas.0914004107","article-title":"Cosmc is an essential chaperone for correct protein O-glycosylation","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","article-title":"Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration","volume":"37","author":"Starossom","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bbagen.2026.130931_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2024.109242","article-title":"Putting a cap on the glycome: dissecting human sialyltransferase functions","volume":"544","author":"Mohamed","year":"2024","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bbagen.2026.130931_bb0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10719-019-09876-0","article-title":"Stuck on sugars \u2013 how carbohydrates regulate cell adhesion, recognition, and signaling","volume":"36","author":"Cummings","year":"2019","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbagen.2026.130931_bb0275","doi-asserted-by":"crossref","DOI":"10.1093\/glycob\/cwae093","article-title":"Galectin-3 disrupts tight junctions of airway epithelial cell monolayers by inducing expression and release of matrix metalloproteinases upon influenza A infection","volume":"35","author":"Iqbal","year":"2025","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2026.130931_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao5610","article-title":"Recurrent infection progressively disables host protection against intestinal inflammation","volume":"358","author":"Yang","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2026.130931_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.883079","article-title":"Mammalian neuraminidases in immune-mediated diseases: mucins and beyond","volume":"13","author":"Lillehoj","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0290","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c01612","article-title":"Human neuraminidases\u00a0: structures and Stereoselective inhibitors","author":"Bourguet","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/diseases10040114","article-title":"Sialyltransferases and neuraminidases: potential targets for cancer treatment","volume":"10","author":"Nag","year":"2022","journal-title":"Diseases"},{"key":"10.1016\/j.bbagen.2026.130931_bb0300","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/glycob\/cws057","article-title":"Mammalian sialidases: physiological and pathological roles in cellular functions","volume":"22","author":"Miyagi","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2026.130931_bb0305","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1471-4159.2009.06339.x","article-title":"Sialidase occurs in both membranes of the nuclear envelope and hydrolyzes endogenous GD1a","volume":"111","author":"Wang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.120.018756","article-title":"Neuraminidases 1 and 3 trigger atherosclerosis by desialylating low-density lipoproteins and increasing their uptake by macrophages","volume":"10","author":"Demina","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbagen.2026.130931_bb0315","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fchem.2019.00791","article-title":"Neuraminidase-3 is a negative regulator of LFA-1 adhesion","volume":"7","author":"Howlader","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0320","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/glycob\/cwv026","article-title":"NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels","volume":"25","author":"Mozzi","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2026.130931_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107671","article-title":"Cellular translocation and secretion of sialidases","volume":"300","author":"Aljohani","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0330","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2019.215830","article-title":"The role of neuraminidase 1 and 2 in glycoprotein Ib\u03b1-mediated integrin \u03b1IIb\u03b23 activation","volume":"105","author":"Van Der Wal","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bbagen.2026.130931_bb0335","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41419-017-0191-4","article-title":"Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt\/mTOR-mediated pathway in pancreatic cancer cells","volume":"9","author":"Nath","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbagen.2026.130931_bb0340","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10719-010-9281-6","article-title":"Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR G\u03b1i proteins and matrix metalloproteinase-9","volume":"27","author":"Finlay","year":"2010","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbagen.2026.130931_bb0345","doi-asserted-by":"crossref","first-page":"13202","DOI":"10.1074\/jbc.M115.638759","article-title":"Rapid trimming of cell surface polysialic acid (PolySia) by exovesicular sialidase triggers release of preexisting surface neurotrophin","volume":"290","author":"Sumida","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0350","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10719-009-9239-8","article-title":"Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase","volume":"26","author":"Amith","year":"2009","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbagen.2026.130931_bb0355","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jnc.15024","article-title":"Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of toll-like receptor 4","volume":"155","author":"Allendorf","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0360","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.1502532","article-title":"Activated microglia Desialylate and phagocytose cells via neuraminidase, Galectin-3, and Mer tyrosine kinase","volume":"198","author":"Nomura","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2022.917884","article-title":"Neu1 is released from activated microglia, stimulating microglial phagocytosis and sensitizing neurons to glutamate","volume":"16","author":"Allendorf","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0370","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood-2011-05-355628","article-title":"Desialylation accelerates platelet clearance after refrigeration and initiates GPIb\u03b1 metalloproteinase-mediated cleavage in mice","volume":"119","author":"Jansen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2026.130931_bb0375","doi-asserted-by":"crossref","DOI":"10.1021\/acscentsci.3c01066","article-title":"Microglia mediate contact-independent neuronal network remodeling via secreted Neuraminidase-3 associated with extracellular vesicles","author":"Delaveris","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0380","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acs.biochem.7b00665","article-title":"Exosomes secreted by HeLa cells shuttle on their surface the plasma membrane-associated Sialidase NEU3","volume":"56","author":"Paolini","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2026.130931_bb0385","doi-asserted-by":"crossref","first-page":"21052","DOI":"10.1074\/jbc.M111.231191","article-title":"Regulation of Sialyl Lewis antigen expression in Colon Cancer cells by Sialidase NEU4","volume":"286","author":"Shiozaki","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0390","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1074\/jbc.M112.404327","article-title":"NEU3 sialidase is activated under hypoxia and protects skeletal muscle cells from apoptosis through the activation of the epidermal growth factor receptor signaling pathway and the hypoxia-inducible factor (HIF)-1\u03b1","volume":"288","author":"Scaringi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0395","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2016.12.123","article-title":"NEU3 sialidase role in activating HIF-1\u03b1 in response to chronic hypoxia in cyanotic congenital heart patients","volume":"230","author":"Piccoli","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110927","article-title":"Desialylation of ATG5 by sialidase (NEU1) promotes macrophages autophagy and exacerbates inflammation under hypoxia","volume":"112","author":"Zeng","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbagen.2026.130931_bb0405","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.1074\/jbc.M112.346817","article-title":"NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not","volume":"287","author":"Cross","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0410","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1074\/jbc.M114.555888","article-title":"NEU1 sialidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia","volume":"289","author":"Lee","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0415","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1194\/jlr.M800002-JLR200","article-title":"Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a","volume":"49","author":"Mukherjee","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbagen.2026.130931_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.151098","article-title":"Sialidase NEU3 silencing inhibits angiogenesis of EA.hy926 cells by regulating Wnt\/\u03b2-catenin signaling pathway","volume":"742","author":"Wu","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2026.130931_bb0425","article-title":"Neu3 neuraminidase induction triggers intestinal inflammation and colitis in a model of recurrent human food-poisoning","volume":"118","author":"Yang","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0430","doi-asserted-by":"crossref","DOI":"10.1093\/glycob\/cwx108","article-title":"Targeting sialic acid\u2013Siglec interactions to reverse immune suppression in cancer","author":"Adams","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2026.130931_bb0435","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bjd\/ljad517","article-title":"The sialic acid\u2013Siglec immune checkpoint: an opportunity to enhance immune responses and therapy effectiveness in melanoma","volume":"190","author":"Coccimiglio","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0440","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1021\/acscentsci.5c00510","article-title":"Targeting Sialidase to PD1 enhances T cell function and tumor control","volume":"11","author":"Garabedian","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0445","author":"Palleon Pharmaceuticals, Inc"},{"key":"10.1016\/j.bbagen.2026.130931_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.962908","article-title":"ST6Gal1: oncogenic signaling pathways and targets","volume":"9","author":"GC","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0455","first-page":"983","article-title":"ST6GAL1: a key player in cancer","volume":"18","author":"Garnham","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbagen.2026.130931_bb0460","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/path.6152","article-title":"ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression","volume":"261","author":"Scott","year":"2023","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329014","article-title":"A novel sialylation pathway mediated by extracellular vesicles in aggressive prostate cancer","volume":"20","author":"Bach","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2026.130931_bb0470","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1172\/JCI129025","article-title":"Galectin-1\u2013driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance","volume":"129","author":"Nambiar","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2026.130931_bb0475","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.166470","article-title":"Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption","author":"Kho","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbagen.2026.130931_bb0480","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12885-017-3251-3","article-title":"Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients","volume":"17","author":"Urup","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbagen.2026.130931_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106984","article-title":"Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1","volume":"26","author":"Rudjord-Levann","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bbagen.2026.130931_bb0490","series-title":"Mature and Migratory Dendritic Cells Promote Immune Infiltration and Response to Anti-PD-1 Checkpoint Blockade in Metastatic Melanoma","author":"Yang","year":"2024"},{"key":"10.1016\/j.bbagen.2026.130931_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.716055","article-title":"Stromal Galectin-1 promotes colorectal cancer cancer-initiating cell features and disease dissemination through SOX9 and \u03b2-catenin: development of niche-based biomarkers","volume":"11","author":"Peng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0500","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molimm.2023.02.011","article-title":"Galectin-1 mediates interactions between polymorphonuclear leukocytes and vascular endothelial cells, and promotes their extravasation during lipopolysaccharide-induced acute lung injury","volume":"156","author":"Feng","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0505","doi-asserted-by":"crossref","DOI":"10.1021\/jm301892f","article-title":"Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2022.835757","article-title":"Inhibitors of human neuraminidase enzymes block transmigration in vitro","volume":"9","author":"Howlader","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2021.802502","article-title":"Neuraminidase1 inhibitor protects against doxorubicin-induced cardiotoxicity via suppressing Drp1-dependent mitophagy","volume":"9","author":"Qin","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0520","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf8169","article-title":"Structure of the immunoregulatory sialidase NEU1","volume":"9","author":"Gorelik","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbagen.2026.130931_bb0525","article-title":"Extracellular vesicles and the tumour microenvironment","volume":"1880","author":"Bel\u00e9nyesi","year":"2025","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"key":"10.1016\/j.bbagen.2026.130931_bb0530","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbagen.2026.130931_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108340","article-title":"Profiling the regulatory landscape of sialylation through miRNA targeting of CMP- sialic acid synthetase","volume":"301","author":"Jame-Chenarboo","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0540","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1074\/jbc.C113.546713","article-title":"Platelets support extracellular sialylation by supplying the sugar donor substrate","volume":"289","author":"Lee","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130931_bb0545","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1158\/0008-5472.CAN-15-2834","article-title":"The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype","volume":"76","author":"Schultz","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130931_bb0550","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13190","article-title":"Glycome profiling by lectin microarray reveals dynamic glycan alterations during epidermal stem cell aging","volume":"19","author":"Oinam","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbagen.2026.130931_bb0555","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-083024-030822","article-title":"Glycan-binding proteins in immunity","author":"Rabinovich","year":"2026","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0560","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"Voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbagen.2026.130931_bb0565","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2026.130931_bb0570","series-title":"Fast Gene Set Enrichment Analysis","author":"Korotkevich","year":"2016"},{"key":"10.1016\/j.bbagen.2026.130931_bb0575","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2026.130931_bb0580","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database Hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.bbagen.2026.130931_bb0585","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","article-title":"UCell: robust and scalable single-cell gene signature scoring","volume":"19","author":"Andreatta","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbagen.2026.130931_bb0590","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/glycob\/cwz045","article-title":"Updates to the symbol nomenclature for Glycans guidelines","volume":"29","author":"Neelamegham","year":"2019","journal-title":"Glycobiology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:31:13Z","timestamp":1793943073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":118,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0304416526000310"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130931","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of sialidases in Galectin-1-associated resistance to cancer therapies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130931"}}